Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of H4:IC31 and BCG revaccination in healthy adolescents
PACTR201512001069358Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of H4:IC31, bcg vaccine, Placebo-COD Research Private Ltd in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Feb 2014; status: completed.
02
Drugs
H4:IC31bcg vaccinePlacebo-COD Research Private Ltd
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201512001069358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201512001069358.